RAPP insider trading
Purchases, sales and option exercises by company officers, directors and 10% owners, as reported to the SEC on Form 4.
- Insider purchases
- $1.71M
- 7 open-market buys, last 14 days
- Insider sales
- $64.45K
- 1 open-market sales, last 14 days
- Buy / sell ratio
- 26.57
- Dollar value bought per dollar sold
- Cluster buys
- 1
- Symbols bought by 2+ insiders
8 transactions · Oct 19 – Nov 1
| Date | Symbol | Insider | Type | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 28 | RAPP Rapport Therapeutics, Inc. | HEALY JAMES Director | Buy | 3,772 | 21.00 | $79.21K | 14.92K | Form 4filing for HEALY JAMES (opens SEC.gov) |
| Oct 23 | RAPP Rapport Therapeutics, Inc. | Sanchez Ramiro Director | Buy | 3,600 | 27.35 | $98.48K | 3.60K | Form 4filing for Sanchez Ramiro (opens SEC.gov) |
| Oct 22 | RAPP Rapport Therapeutics, Inc. | PAUL STEVEN M Director | Buy | 35,714 | 27.28 | $974.28K | 77.38K | Form 4filing for PAUL STEVEN M (opens SEC.gov) |
| Oct 22 | RAPP Rapport Therapeutics, Inc. | MARAGANORE JOHN Director | Buy | 8,239 | 26.38 | $217.34K | 8.24K | Form 4filing for MARAGANORE JOHN (opens SEC.gov) |
| Oct 22 | RAPP Rapport Therapeutics, Inc. | Young Wendy B. Director | Buy | 3,789 | 26.39 | $99.99K | 13.29K | Form 4filing for Young Wendy B. (opens SEC.gov) |
| Oct 22 | RAPP Rapport Therapeutics, Inc. | Silva Paul M Director | Buy | 3,680 | 27.08 | $99.64K | 3.68K | Form 4filing for Silva Paul M (opens SEC.gov) |
| Oct 21 | RAPP Rapport Therapeutics, Inc. | Ignelzi Troy A. Chief Financial Officer | Buy | 5,500 | 26.10 | $143.55K | 15.50K | Form 4filing for Ignelzi Troy A. (opens SEC.gov) |
| Oct 21 | RAPP Rapport Therapeutics, Inc. | Ceesay Abraham Director, Chief Executive Officer | Sale | 2,210 | 29.16 | $64.45K | 450.04K | Form 4filing for Ceesay Abraham (opens SEC.gov) |
Source: SEC Form 4 filings. Value is shares × reported price; option exercises are often reported without a price. Awards, gifts and tax-withholding transactions are not shown. Not investment advice.